The Scientist

» reagents, culture and cell & molecular biology

Most Recent

image: Opinion: Scientists’ Intuitive Failures

Opinion: Scientists’ Intuitive Failures

By | July 23, 2012

Much of what researchers believe about the public and effective communication is wrong.

26 Comments

image: Microbial Perfume

Microbial Perfume

By | July 23, 2012

Much of what researchers believe about the public and effective communication is wrong.

4 Comments

image: EU Promotes Collaboration

EU Promotes Collaboration

By | July 18, 2012

Much of what researchers believe about the public and effective communication is wrong.

0 Comments

image: UK Pushes Open Access

UK Pushes Open Access

By | July 16, 2012

Much of what researchers believe about the public and effective communication is wrong.

1 Comment

image: Another Victim of Suspicious Data

Another Victim of Suspicious Data

By | July 13, 2012

Much of what researchers believe about the public and effective communication is wrong.

2 Comments

image: Scorpion Venom Kills MRSA

Scorpion Venom Kills MRSA

By | July 12, 2012

Much of what researchers believe about the public and effective communication is wrong.

2 Comments

image: Last Chance for 2012 Salary Survey

Last Chance for 2012 Salary Survey

By | July 10, 2012

Much of what researchers believe about the public and effective communication is wrong.

0 Comments

image: Anesthesiologist Fabricates 172 Papers

Anesthesiologist Fabricates 172 Papers

By | July 3, 2012

Much of what researchers believe about the public and effective communication is wrong.

10 Comments

image: Capsule Reviews

Capsule Reviews

By | July 1, 2012

Much of what researchers believe about the public and effective communication is wrong.

0 Comments

Much of what researchers believe about the public and effective communication is wrong.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech